JP2010509372A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509372A5
JP2010509372A5 JP2009536541A JP2009536541A JP2010509372A5 JP 2010509372 A5 JP2010509372 A5 JP 2010509372A5 JP 2009536541 A JP2009536541 A JP 2009536541A JP 2009536541 A JP2009536541 A JP 2009536541A JP 2010509372 A5 JP2010509372 A5 JP 2010509372A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
substituted
unsubstituted
group
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009536541A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509372A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/084573 external-priority patent/WO2008064015A1/en
Publication of JP2010509372A publication Critical patent/JP2010509372A/ja
Publication of JP2010509372A5 publication Critical patent/JP2010509372A5/ja
Pending legal-status Critical Current

Links

JP2009536541A 2006-11-13 2007-11-13 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法 Pending JP2010509372A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85850906P 2006-11-13 2006-11-13
PCT/US2007/084573 WO2008064015A1 (en) 2006-11-13 2007-11-13 Methods for preserving renal function using xanthine oxidoreductase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013195396A Division JP2014012726A (ja) 2006-11-13 2013-09-20 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法

Publications (2)

Publication Number Publication Date
JP2010509372A JP2010509372A (ja) 2010-03-25
JP2010509372A5 true JP2010509372A5 (https=) 2010-08-19

Family

ID=39430048

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009536541A Pending JP2010509372A (ja) 2006-11-13 2007-11-13 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法
JP2013195396A Pending JP2014012726A (ja) 2006-11-13 2013-09-20 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法
JP2016114133A Expired - Fee Related JP6233899B2 (ja) 2006-11-13 2016-06-08 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013195396A Pending JP2014012726A (ja) 2006-11-13 2013-09-20 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法
JP2016114133A Expired - Fee Related JP6233899B2 (ja) 2006-11-13 2016-06-08 キサンチン酸化還元酵素阻害剤を使用する腎機能保持方法

Country Status (11)

Country Link
US (1) US20080269226A1 (https=)
EP (1) EP2101761A4 (https=)
JP (3) JP2010509372A (https=)
KR (3) KR20150024919A (https=)
CN (1) CN101677999A (https=)
AU (1) AU2007323919A1 (https=)
BR (1) BRPI0718611A2 (https=)
CA (1) CA2669935A1 (https=)
MX (1) MX2009004984A (https=)
RU (1) RU2508099C2 (https=)
WO (1) WO2008064015A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1883405A4 (en) * 2005-05-09 2010-01-27 Takeda Pharmaceuticals North A METHODS OF TREATING NEPHROLITHIASIS
JP5242393B2 (ja) * 2005-08-03 2013-07-24 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 高血圧症の治療方法
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
AU2008206231A1 (en) * 2007-01-19 2008-07-24 Takeda Pharmaceuticals U.S.A., Inc. Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
IT1400310B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e statine e loro uso.
IT1400609B1 (it) 2010-05-10 2013-06-14 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e metformina e loro uso.
IT1400309B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
IT1400311B1 (it) 2010-05-10 2013-05-24 Menarini Int Operations Lu Sa Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
SG186301A1 (en) 2010-06-16 2013-02-28 Takeda Pharmaceuticals Usa Inc Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
AR082022A1 (es) * 2010-06-25 2012-11-07 Teijin Pharma Ltd Agente terapeutico de liberacion sostenida para la hipertension y la disfuncion renal
CN102372679A (zh) * 2010-08-27 2012-03-14 北京润德康医药技术有限公司 一种非布司他水溶性衍生物及其制备方法
CA2812034C (en) 2010-09-10 2018-10-23 Takeda Pharmaceuticals U.S.A., Inc. Methods for concomitant treatment of theophylline and febuxostat
WO2012060308A1 (ja) * 2010-11-01 2012-05-10 株式会社 三和化学研究所 腎機能障害の予防又は治療に用いる医薬
CN102757403B (zh) * 2011-04-27 2015-04-29 浙江九洲药业股份有限公司 一种非布索坦衍生物及其制备方法
TW201328692A (zh) * 2011-10-11 2013-07-16 Univ Osaka 脫髓鞘疾病之治療劑及預防劑
BR112014017902A2 (pt) 2012-01-27 2017-08-22 Teijin Pharma Limited E National Univ Corporation Tottori Univ Agente terapêutico ou profilático para doenças causadas por distúrbios do metabolismo de glicose
KR20150073963A (ko) * 2012-10-23 2015-07-01 데이진 화-마 가부시키가이샤 종양 융해 증후군의 치료약 및 예방약
CN103265636B (zh) * 2013-05-23 2015-09-16 中国药科大学 一种具有降血糖作用的新型肽
CN104548066A (zh) * 2015-01-19 2015-04-29 中国药科大学 一种具有降血糖作用的新型肽的新用途
CN105294584A (zh) * 2015-11-30 2016-02-03 中国医科大学 1-取代苯基-1h-1,2,3-三唑类化合物、制备方法及其用途
ES2842577T3 (es) 2016-02-19 2021-07-14 Nezu Life Science Co Ltd Fármaco terapéutico o profiláctico para la demencia
CN106279024B (zh) * 2016-07-19 2018-09-14 华南理工大学 一种黄嘌呤氧化还原酶抑制剂及其制备方法与应用
KR20230119303A (ko) * 2022-02-07 2023-08-16 (주)인드림헬스케어 높은 혈중 요산 농도를 갖는 대상체의 만성 신장 질환의 예방 또는 치료를 위한 알로푸리놀, 페북소스타트 또는 이들의 약학적으로 허용 가능한 염을 포함하는 약제학적 조성물

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US4058614A (en) * 1973-12-04 1977-11-15 Merck & Co., Inc. Substituted imidazole compounds and therapeutic compositions therewith
US4296122A (en) * 1975-07-09 1981-10-20 Merck & Co., Inc. 2,3-Dihydro-6,7-disubstituted-5-(acyl)benzofuran-2-carboxylic acids
DE2727802A1 (de) * 1977-06-21 1979-04-19 Hoechst Ag Sulfamoyl-arylketone und verfahren zu ihrer herstellung
US4510322A (en) * 1981-07-13 1985-04-09 Merck & Co., Inc. Indacrinone having enhanced uricosuric
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
JPH0366669A (ja) * 1989-08-03 1991-03-22 Shionogi & Co Ltd 複素環式化合物
DK0513379T3 (da) * 1990-11-30 1996-09-30 Teijin Ltd 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
US5358961A (en) * 1991-11-30 1994-10-25 Jin Ro Limited Pyrrolidine derivatives
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5770601A (en) * 1994-08-17 1998-06-23 Virginia Tech Intellectual Properties, Inc. Compositions and methods for controlling pest insects
US5514681A (en) * 1994-08-17 1996-05-07 Virginia Tech Intellectual Properties, Inc. Compositions and methods for controlling pest insects
US6037344A (en) * 1994-08-17 2000-03-14 Virginia Tech Intellectual Properties, Inc. Compositions and methods for controlling pest insects
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
CA2190993C (en) * 1995-04-07 2004-06-01 Mikio Ota Protective agent for organ or tissue
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
US5965625A (en) * 1997-03-21 1999-10-12 King; Michael Glenn Compositions and methods for the control of smoking
US6191136B1 (en) * 1997-11-07 2001-02-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
CN1275126A (zh) * 1998-06-19 2000-11-29 帝人株式会社 2－(3－氰基－4－异丁氧基苯基)－4－甲基－5－噻唑甲酸的多晶型体及其制备方法
US6281222B1 (en) * 1999-08-19 2001-08-28 Inotek Corporation Compositions and method for treatment of acetaminophen intoxication
JP2004517804A (ja) * 2000-06-28 2004-06-17 メルク・アンド・カンパニー・インコーポレーテッド 心臓血管病の治療法
ITMI20010206A1 (it) * 2001-02-02 2002-08-02 Dompe Spa Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz
BR0209133A (pt) * 2001-04-18 2004-06-15 Genzyme Corp Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
NZ531673A (en) * 2002-01-28 2006-06-30 Fuji Yakuhin Co Novel 1,2,4-triazole compounds
CN1642546A (zh) * 2002-03-28 2005-07-20 帝人株式会社 含有单一晶型的固体制剂
US20060040945A1 (en) * 2002-05-17 2006-02-23 Merckle Gmbh Annellated pyrrole compounds as proton pump inhibitors for treating ulcer
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
US20040122067A1 (en) * 2002-12-20 2004-06-24 Lin Zhao Treatment of chronic heart failure
US20040131676A1 (en) * 2002-12-20 2004-07-08 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
WO2005018635A2 (en) * 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
WO2006028342A1 (en) * 2004-09-06 2006-03-16 Biosynergen, Inc. A novel xanthine oxidase inhibitor and a pharmaceutical composition containing the same
WO2006055412A1 (en) * 2004-11-19 2006-05-26 Shiva Biomedical, Llc Methods of treating erythropoietin-resistance
EP1883405A4 (en) * 2005-05-09 2010-01-27 Takeda Pharmaceuticals North A METHODS OF TREATING NEPHROLITHIASIS
JP5242393B2 (ja) * 2005-08-03 2013-07-24 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド 高血圧症の治療方法
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
AU2008206231A1 (en) * 2007-01-19 2008-07-24 Takeda Pharmaceuticals U.S.A., Inc. Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
CA2812034C (en) * 2010-09-10 2018-10-23 Takeda Pharmaceuticals U.S.A., Inc. Methods for concomitant treatment of theophylline and febuxostat

Similar Documents

Publication Publication Date Title
JP2010509372A5 (https=)
RU2009122505A (ru) Способы сохранения функции почек с использованием ингибиторов ксантин оксидоредуктазы
RU2326881C9 (ru) Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k)
AU2003254650B2 (en) Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
JP2013539747A5 (https=)
JP2007523182A5 (https=)
JP2010513272A5 (https=)
JP2008513515A5 (https=)
JP2011507868A5 (https=)
RU2015132105A (ru) Азоловые производные бензола
JP2011504935A5 (https=)
JP2008513514A5 (https=)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2005537312A5 (https=)
JP2009503094A5 (https=)
JP2009523812A5 (https=)
ME02100B (me) Derivati 4-aminopirimidina i njihova primena kao antagonista adenozinskog a2a receptora
JP2005511608A5 (https=)
RU2013109380A (ru) Способ сопутствующей терапии с применением теофиллина и фебуксостата
JP2014525444A5 (https=)
JP2007500703A5 (https=)
US20110237783A1 (en) Hydrazonopyrazole derivatives and their use as therapeutics
JP2014532070A5 (https=)
JP2007501189A5 (https=)
JP2010513304A5 (https=)